Matches in Nanopublications for { ?s ?p "[High expression of CCNE2, but not CCNE1, was characteristic of the luminal B and HER2 subtypes of breast cancer and was strongly predictive of shorter distant metastasis-free survival following endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP662001.RAsA2o12M1K-3-YUx_EWsIK7niSF4ycqE4ACIGPr--6Hs130_assertion description "[High expression of CCNE2, but not CCNE1, was characteristic of the luminal B and HER2 subtypes of breast cancer and was strongly predictive of shorter distant metastasis-free survival following endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662001.RAsA2o12M1K-3-YUx_EWsIK7niSF4ycqE4ACIGPr--6Hs130_provenance.
- NP480296.RAeJfBLECWheJtFxr8zehq1Q_VB4NXF2SeLxpjCuPNPIg130_assertion description "[High expression of CCNE2, but not CCNE1, was characteristic of the luminal B and HER2 subtypes of breast cancer and was strongly predictive of shorter distant metastasis-free survival following endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480296.RAeJfBLECWheJtFxr8zehq1Q_VB4NXF2SeLxpjCuPNPIg130_provenance.
- NP482822.RAWgc60flS0OYrnUYkBpI_siGqXRvuJXzgQZUFItED_kU130_assertion description "[High expression of CCNE2, but not CCNE1, was characteristic of the luminal B and HER2 subtypes of breast cancer and was strongly predictive of shorter distant metastasis-free survival following endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482822.RAWgc60flS0OYrnUYkBpI_siGqXRvuJXzgQZUFItED_kU130_provenance.
- NP740980.RABHrF9Q_gen5JjtYIwOF71gCMF-64kwr7AwlRBvDSvjU130_assertion description "[High expression of CCNE2, but not CCNE1, was characteristic of the luminal B and HER2 subtypes of breast cancer and was strongly predictive of shorter distant metastasis-free survival following endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740980.RABHrF9Q_gen5JjtYIwOF71gCMF-64kwr7AwlRBvDSvjU130_provenance.
- NP213291.RALhoipP9WRggxzsT2swAuSja1y2t6jefatsmahx_y3YQ130_assertion description "[High expression of CCNE2, but not CCNE1, was characteristic of the luminal B and HER2 subtypes of breast cancer and was strongly predictive of shorter distant metastasis-free survival following endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP213291.RALhoipP9WRggxzsT2swAuSja1y2t6jefatsmahx_y3YQ130_provenance.
- assertion description "[High expression of CCNE2, but not CCNE1, was characteristic of the luminal B and HER2 subtypes of breast cancer and was strongly predictive of shorter distant metastasis-free survival following endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[High expression of CCNE2, but not CCNE1, was characteristic of the luminal B and HER2 subtypes of breast cancer and was strongly predictive of shorter distant metastasis-free survival following endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[High expression of CCNE2, but not CCNE1, was characteristic of the luminal B and HER2 subtypes of breast cancer and was strongly predictive of shorter distant metastasis-free survival following endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[High expression of CCNE2, but not CCNE1, was characteristic of the luminal B and HER2 subtypes of breast cancer and was strongly predictive of shorter distant metastasis-free survival following endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP854530.RA-DOJqvvnOAoBV8r-Y4SgG7r8j7k9u5PMZy_F-Gq5urE130_assertion description "[High expression of CCNE2, but not CCNE1, was characteristic of the luminal B and HER2 subtypes of breast cancer and was strongly predictive of shorter distant metastasis-free survival following endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854530.RA-DOJqvvnOAoBV8r-Y4SgG7r8j7k9u5PMZy_F-Gq5urE130_provenance.
- NP980236.RAs3N__z8grjW4-qfRvsV_PfoPNGsFN9VrRrWL5j2GDAc130_assertion description "[High expression of CCNE2, but not CCNE1, was characteristic of the luminal B and HER2 subtypes of breast cancer and was strongly predictive of shorter distant metastasis-free survival following endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980236.RAs3N__z8grjW4-qfRvsV_PfoPNGsFN9VrRrWL5j2GDAc130_provenance.
- NP980233.RAOuXBvpLn7I8OivFowyPoycAiMtr8mHuMAeQ2VM8RAHI130_assertion description "[High expression of CCNE2, but not CCNE1, was characteristic of the luminal B and HER2 subtypes of breast cancer and was strongly predictive of shorter distant metastasis-free survival following endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980233.RAOuXBvpLn7I8OivFowyPoycAiMtr8mHuMAeQ2VM8RAHI130_provenance.
- NP980238.RAOSP4Is-D8r1hZJTDDoma33N0PZ950koi8uzN5O4N-zo130_assertion description "[High expression of CCNE2, but not CCNE1, was characteristic of the luminal B and HER2 subtypes of breast cancer and was strongly predictive of shorter distant metastasis-free survival following endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980238.RAOSP4Is-D8r1hZJTDDoma33N0PZ950koi8uzN5O4N-zo130_provenance.